We value your privacy
We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies.
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
No cookies to display.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
No cookies to display.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
No cookies to display.
Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.
No cookies to display.
Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.
No cookies to display.
During ANS testing, which takes about 30 minutes, the patient’s blood pressure, heart rate and electrical dermal activity is measured during tasks such as standing up from a sitting position, squeezing a dynamometer and various other physical and cognitive exercises.
Sleep questionnaires are also administered given the high correlation between ANS over arousal disorder and insomnia.
Approximately 65% of patients with anxiety related disorders have ANS over arousal which is often the primary etiology underlying the anxiety disorder.
ANS over arousal disorders generally responds well to somatic therapies such as neuromodulation of the amygdala and SSRI pharmacological therapies.
Email: info@neuroci.com
Tel: (973) 601-0100
Toll-Free: 1-888-NCI-9664
Fax: (973) 440-1656